Outcomes of Acute Kidney Injury in Neonates

Slides:



Advertisements
Similar presentations
AKI in Pediatrics Patrick D. Brophy MD Associate Professor
Advertisements

Prevention of Contrast-Induced Nephropathy (CIN) Sepehr Khashaei, MD Assistant professor Department of Internal Medicine.
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Fluid and Electrolyte Homeostasis in the Neonate
Renal Protection for Coronary Angiography in Advanced Renal Failure Patients by Prophylactic Hemodialysis Presented by Mike Touchy, HO-I.
A Randomized Trial of Protocol-Based Care for Early Septic Shock Andrea Caballero, MD January 15, 2015 LSU Journal Club The ProCESS Investigators. N Engl.
David Askenazi MD MSPH pCRRT meeting September 28, 2012
ECMO in CRRT – What are the Data?
Pediatric Bone Marrow Transplant Recipients with Acute Renal Failure Stuart L. Goldstein, MD Assistant Professor of Pediatrics Baylor College of Medicine.
AKI Definitions Stuart L. Goldstein, MD Professor of Pediatrics University of Cincinnati College of Medicine Director, Center for Acute Care Nephrology.
The Limits of Viability: How Small Is Too Small?
PCRRT in ECMO Norma Maxvold MD Associate Professor of Pediatrics Children’s Hospital of Richmond-VCU.
Pediatric Acute Renal Failure: CRRT/Dialysis Outcome Studies Stuart L. Goldstein, MD Assistant Professor of Pediatrics Baylor College of Medicine.
The long-term outcome after acute renal failure Presented by Ri 顏玎安.
Erika F Fernandez MD Assistant Professor Department of Pediatrics, Division of Neonatology Adrenal function in critically ill term newborn infants.
1 TREATMENT STRATEGIES FOR AKI AFTER CPB (FENOLDOPAM, EARLY PD) STEFANO PICCA and ZACCARIA RICCI Dialysis Unit- Dept of Nephrology and Urology CICU- Dept.
Pediatric ECMO and CRRT
PREDICTING AKI IS MORE CHALLENGING AS AGE PROGRESSES Sandra Kane-Gill, PharmD, MSc Associate Professor, School of Pharmacy.
The Relationship between Acute Kidney Injury and Brain MRI Findings in Asphyxiated Newborns after Therapeutic Hypothermia David T Selewski, MD 1, David.
AKI ITSELF EPIDEMIOLOGY Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.
Sean M Bagshaw, MD, MSc Division of Critical Care Medicine Faculty of Medicine and Dentistry, University of Alberta 1 st International Symposium on AKI.
 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.
Acute Kidney Injury after Cardiopulmonary Bypass Catherine Krawczeski, MD Associate Professor of Pediatrics University of Cincinnati College of Medicine.
Acute Kidney Injury in Neonates Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA - USA 8th International.
"AKI in Critical Care: epidemiology and definitions" Stefano Picca, MD Department of Nephrology and Urology, Dialysis Unit “Bambino Gesù” Pediatric Research.
Journal Club : Relationship between Intraoperative Mean Arterial Pressure and Clinical Outcomes after Noncardiac Surgery Toward an Empirical Definition.
Use of CRRT in ECMO: Is It Valuable? James D. Fortenberry MD, FCCM, FAAP Associate Professor of Pediatrics Emory University School of Medicine Director,
Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Major Clinical Trials in AKI Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.
THE EFFECT OF TIMING OF INITITIATION OF CRRT ON PATIENTS REQUIRING EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) Asif Mansuri, MD, MRCPI Fellow, Division.
ACUTE RENAL FAILURE 吳志仁 醫師 馬偕醫院 腎臟內科. Definition An increase Cr. ≧ 0.5 mg/dl per day An increase of more than 50 % over baseline Cr. A reduction in calculated.
Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.
Use of CRRT in ECMO: Is It Valuable? James D. Fortenberry MD, FCCM, FAAP Associate Professor of Pediatrics Emory University School of Medicine Director,
Renal Replacement Therapy for Prevention of Contrast- induced Acute Kidney Injury: A Meta-analysis of Randomized Controlled Trials Source Song K, Jiang.
Renal Replacement Therapy in the CICU Stuart L. Goldstein, MD Professor of Pediatrics University or Cincinnati College of Medicine Director, Center for.
Insert Program or Hospital Logo Texas Pediatric Society Electronic Poster Contest Hypoglycemia and Hyperglycemia are Associated with Poor Outcome in Neonatal.
AKI in critically ill cancer patients: do we need more studies? : No !
TAVR in Patients With Chronic Kidney Disease
An AKI project for critically ill cancer patients
Introduction to the Child health Nursing and Nutritional Need
University of Alabama at Birmingham
World Kidney Day 2016: Kidney Disease & Children
Nephrology Journal Club The SPRINT Trial Parker Gregg
Acute Kidney Injury (AKI)
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
When fluids go wrong: CRRT in fluid overload
AKI in critically ill cancer patients:
When to start CRRT during ECMO?
Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.
Vascular Access and Infused Fluids for Pediatric CRRT
DEBATE: Timing of CRRT in Critical Care
Does Hyponatremia in Asphyxiated Newborn infants correlate with incidence of death or disability? 1Mohamed S. Elboraee, 1,2Ernest Phillipos, 4Leonora Hendson,
Ageing with ideal cardiovascular risk factors
Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.
Etiology of Acute Kidney Injury in Neonates
Acute Kidney Injury (AKI)
Figure 4 Interplay between acute kidney injury (AKI),
Objectives Early initiation of continuous renal replacement therapy
Figure 2 Milestones in paediatric acute kidney injury (AKI) research
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Risk of perioperative renal dysfunction with N-acetylcysteine or placebo in patients undergoing CABG surgery End point N-acetylcysteine Placebo Relative.
End point Fenoldopam, n (%) Dopamine, n (%) p
J Foland, J Fortenberry, B Warshaw,
Children’s Memorial Hospital Northwestern University
Plasmapheresis With (and Without) CRRT
Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%
Pregnancy outcomes in kidney transplant recipients
Paediatric Sepsis Screening in the Emergency Department
Dr Donal O’Donoghue National Clinical Director for Kidney Care
Presentation transcript:

Outcomes of Acute Kidney Injury in Neonates 9th International pCRRT Conference on Pediatric Continuous Renal Replacement Therapy August 31-September 2, 2017 Outcomes of Acute Kidney Injury in Neonates Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA

Neonatal AKI: How Do We Define It?

Neonatal AKI: Challenging to Define Often non-oliguric Unclear baseline Not steady state Less frequent labs Suboptimal markers Documentation issues Jetton & Askenazi, Clin Perinatol 2014

Neonatal AKI: What Interventions Do We Have?

Management of Established AKI: Pharmacotherapy Attempted Therapies Definitive Therapies Diuretics Mannitol Dopamine Fenoldopam Glucocorticoids Atrial natriuretic peptide N-acetylcysteine (other than contrast-induced AKI Hmmmm . . . . .

Prophylaxis of Neonatal AKI Theophylline may protect asphyxiated infants against AKI: However: Insufficient information on long-term renal or neurodevelopmental outcome Different doses between trials Toxicity remains unclear Unsure of interaction/benefit with hypothermia Al-Wassia et al. J Perinatol 2013

Conservative Management of Established AKI: Traditional Approach Limit fluid intake Limit input of retained substances Augment losses (diuretics) Try not to mess up Wait and Hope

Renal Replacement Therapy for Neonatal AKI

Renal Replacement Therapy for Neonatal AKI A New Era in Neonatal CRRT

Neonatal AKI: What About Outcomes?

Low Birthweight and AKI Study Population Results Koralkar1 VLBW (N=229) AKI incidence 18% Mortality 42% vs. 5% without AKI HR for death 9.3 (95% CI 4.1-21.0) Viswanathan2 ELBW (N=472; 46 AKI, 46 matched controls) AKI incidence 12.5% overall (59/472) Case mortality rate 70% in cases vs. 22% in controls Carmody3 VLBW (N=455) AKI incidence 39.8% More common in sicker infants (CRIB score <10) More common in most premature (gest age <28w) OR for death 4.0 (95% CI 1.4-11.5) 1. Koralkar et al. Pediatr Res 2011 3. Carmody et al. CJASN 2014 2. Viswanathan et al. Pediatr Nephrol 2012

ECMO and AKI Study Population Results Gadepalli1 All congen DH patients on ECMO from 1999-2009 (N=68) AKI incidence 71% Those with highest level of AKI: Lower survival (27% vs 80%; P=0.001) Longer ECMO (314 + 145 vs 197 + 115 hr; P=0.001) Fewer vent-free days in first 60 days of illness Zwiers2 All neonates over 14 year period placed on ECMO (N=242) Overall survival 74% AKI incidence 64% Lower survival to ICU discharge (35%) compared to milder AKI or no AKI (76-82% survival) 1. Gadepalli et al. J Pediatr Surg 2011 2. Zwiers et al. Crit Care 2013

Heart Surgery and AKI Study Population Results Blinder1 Infants <90d old undergoing surgery for CHD (N=430) AKI incidence 52% More severe AKI associated with mortality Stage 2: OR 5.1 (95% CI 1.7-15.2) Stage 3: OR 9.46 (95% CI 2.91-30.7) AKI also associated with longer ICU stay Al Abbas2 Infants <28d old undergoing surgery for CHD (N=122) AKI incidence 62% Stage 3 AKI associated with: Mortality: OR 6.7 (95% CI 1.08-41.50) Longer ICU stay: HR 9.09 (95% CI 1.35-60.95) 1. Blinder et al. J Thorac Cardiovasc Surg 2012 2. Al Abbas et al. Pediatr Nephrol 2013

Neonatal AKI in a PICU Population <28d old Gest age 38w AKI 35%; more common with Younger infant Bacteremia Higher serum sodium Kriplani et al. PCCM 2016

ppCRRT Data of Infants <10kg: Survival by Weight Group Askenazi et al. J Ped 2013

ppCRRT Data of Infants < 1 Month: Overall Survival

ppCRRT Data of Infants < 1 Month: Survival by Disease Category 73% 25% 33% 100% Totals: N=35 Survivors=15

Therapeutic Hypothermia: Protective Against AKI? Hypothermia standard of care for term infants with perinatal asphyxia RCT of 120 term infants (N=60 each) AKI AKI No AKI No AKI Tanigasalam et al. J Matern-Fetal Neo Med 2016

Neonatal AKI: What’s the Long-Term Outlook?

Risk for CKD After AKI Growing recognition of risk Mammen et al. (AJKD 2012) Up to 3-year follow-up for survivors of pediatric AKI in the ICU Markers of CKD Albuminuria; GFR; blood pressure

Risk for CKD After AKI CKD (low GFR or albuminuria) ~10% Risk of CKD (GFR 60-90; HTN; hyperfiltration) ~47% Mammen et al. AJKD 2012

Likelihood of Renal Recovery in Very Small Infants with AKI Retrospective review of 20 infants ELBW, AKI (mean Cr 2.9), up to 18-yr F/U Compared those with later CKD to normals 9/20 patients went on to develop CKD: Risk factors for progression: Urine Pr/Cr >0.6 at 1 yr Cr >0.6 mg/dL at 1 yr BMI >85th percentile Abitbol et al, Pediatr Nephrol 18:887, 2003

Acute Kidney Injury in Neonates: Summary Neonates are at special risk for AKI Unique physiology Clinical risks Nature of our interventions Like older children and adults, AKI is a significant problem for the newborn Morbidity and mortality Management remains a challenge Meeting the challenge is why we are here!

Good-Bye, AKI!

Thank You for Your Attention!